首页|盐酸替罗非班辅助PCI治疗急性心肌梗死的临床效果

盐酸替罗非班辅助PCI治疗急性心肌梗死的临床效果

扫码查看
目的:探讨盐酸替罗非班辅助经皮冠状动脉介入术(PCI)治疗急性心肌梗死(AMI)的临床效果。方法:选择 2021 年 8 月—2023 年 6 月延边大学附属医院(延边医院)收治的 100 例AMI患者作为研究对象,按随机数表法将其分为观察组(50 例)和对照组(50 例)。对照组行PCI治疗,观察组行盐酸替罗非班辅助PCI治疗。比较两组临床疗效、心功能、心肌损伤标志物、炎症因子及不良反应。结果:观察组临床总有效率高于对照组,差异有统计学意义(P<0。05)。治疗前,两组心功能、心肌损伤标志物及炎症因子水平比较,差异无统计学意义(P>0。05);治疗后,两组左心室射血分数(LVEF)较治疗前升高,且观察组较对照组更高,两组左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、血清肌钙蛋白I(cTnI)、肌酸激酶同工酶(CK-MB)、白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)水平较治疗前降低,且观察组较对照组更低,差异有统计学意义(P<0。05)。两组不良反应发生率比较,差异无统计学意义(P>0。05)。结论:盐酸替罗非班辅助PCI治疗AMI患者效果更佳,能有效改善心功能,减轻心肌损伤,减轻机体炎症反应,安全可靠。
Clinical Effect of Tirofiban Hydrochloride Assisted PCI in the Treatment of Acute Myocardial Infarction
Objective:To investigate the clinical effect of Tirofiban Hydrochloride assisted percutaneous coronary intervention(PCI)in the treatment of acute myocardial infarction(AMI).Method:A total of 100 AMI patients who admitted to Yanbian University Hospital(Yanbian Hospital)from August 2021 to June 2023 were selected as the study objects,and they were randomly divided into the control group(50 cases)and the observation group(50 cases)according to the random number table method.The control group was given PCI treatment,while the observation group was given Tirofiban Hydrochloride assisted PCI treatment.The clinical efficacy,cardiac function,myocardial injury markers,inflammatory factors and adverse reactions between two groups were compared.Result:The total clinical effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).Before treatment,there were no significant differences in the levels of cardiac function,myocardial injury markers and inflammatory factors between two groups(P>0.05);after treatment,the left ventricular ejection fraction(LVEF)in two groups were increased compared with those before treatment,and that in the observation group was higher than that in the control group,the left ventricular end systolic diameter(LVESD),left ventricular end diastolic diameter(LVEDD),levels of serum troponin I(cTnI),creatine kinase isoenzyme(CK-MB),interleukin-6(IL-6)and hypersensitive C-reactive protein(hs-CRP)in two groups were decreased compared with those before treatment,and those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between two groups(P>0.05).Conclusion:Tirofiban Hydrochloride assisted PCI treatment is more effective in the treatment of AMI patients,which can effectively improve cardiac function,reduce myocardial injury,reduce inflammatory reactions,and it is safe and reliable.

Acute myocardial infarctionPercutaneous coronary interventionTirofiban Hydrochloride

崔艺峰

展开 >

延边大学附属医院(延边医院) 吉林 延吉 133000

急性心肌梗死 经皮冠状动脉介入术 盐酸替罗非班

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(15)
  • 18